We Built an App for People Who Couldn't Leave the Room

TL;DR: StatBreaks was a mobile break board and scheduling app for hospital anesthesiology departments. Anesthesiologists were stuck in operating rooms with no way to coordinate breaks — their only tool was a whiteboard down the hall no one could see. SyncTech built StatBreaks to replace the whiteboard with a smartphone. It launched, hospitals used it, acquisition interest came in. Then the founders hit a conflict of interest with their employer and the momentum died. The lesson: a great product can't save a deal where the founders won't bleed for it.

---

Picture this.

You are an anesthesiologist. You have been in an operating room for four hours. You need to use the bathroom. Badly.

You cannot leave.

Not because of the rules. Because there is literally no one to cover you. The patient is under. You are it. So you do what any reasonable professional does — you send a group text to the entire floor.

And you wait.

Sometimes someone comes. Sometimes they forget. Sometimes you are just standing there, in scrubs, quietly suffering, hoping someone checks their phone.

That was the actual problem a group of anesthesiologists walked into our office with. And the "solution" they had been using their entire careers? A whiteboard. In the director's office. Down the hall.

The whiteboard nobody could see from their room.

A digital break board for anesthesiology floors

The idea was simple. Take the whiteboard and make it mobile. Give every anesthesiologist on the floor a live view of who's available, who's in a room, who's been in there the longest. Let them request a break with a tap. Let anyone available accept it. Clock in, clock out, close the loop.

We built a working prototype fast — Ionic on the frontend, .NET on GCP for the backend. We also pushed the founders hard before going deep: prove the pain by talking to at least 100 anesthesiologists. They did. It was real.

When the founders finally saw the prototype, they thought it was a finished product.

"Oh my god. When can we start using it?"

I had to pump the brakes: "None of this is real yet. It's a prototype."

They didn't care. They were already selling it in their heads. When a customer sees a demo and immediately tries to buy the thing — you're pointed at something real.

The problem nobody mentioned upfront

The break board was the pitch. But the deeper pain revealed itself the longer we stayed in the room.

The anesthesiologist director spent three hours every day rebuilding the next day's schedule by hand. Cross-referencing availability, room assignments, coverage needs — all of it manually. Every single day.

So we added scheduling to StatBreaks. Anesthesiologists logged their availability in the app. The system generated a draft. The director reviewed and approved.

Three hours became ten minutes.

You only find that kind of pain by staying in the room past the original problem. The client came to us with one. We found a second one that had been quietly eating three hours of a senior person's day for their entire career.

It launched. The market noticed.

StatBreaks went live. At least one hospital was using it. The founders were being flown around to pitch others. A larger healthcare company approached them about an acquisition to get the product into hospital networks.

The product worked. The market was paying attention.

The problem was never the software. The problem was the people.

This is the part of the story I tell most honestly: I'm a good judge of an idea. I'm a lousy judge of character.

SyncTech was mostly on an equity arrangement with the founding team. The founders eventually hit a conflict of interest with their employer. The urgency faded. The momentum quietly stalled. We transferred the codebase to another team and stayed on as advisors.

The product died.

Equity deals need founders with real skin in the game

Skin in the game matters. Not just ours — the founders'. When someone has real financial stakes that hurt if the thing fails, they show up differently. They push through the hard conversations. They make the uncomfortable decisions. They don't let friction quietly kill the company.

A great equity deal with founders who won't bleed for it is worth less than a smaller deal with founders who will.

That's why, today, we only take equity deals with founders who already have something real on the line.

Why we build things

The anesthesiologist director who saw the demo for the first time lit up like we had just described something they had been waiting for their whole career. Because we had.

That is the part that stays with me. Not the equity deal. Not the acquisition conversation. Not even the whiteboard.

The look on the director's face when they realized the board in their office — the one they had been walking to and from every day for years — was finally going to fit in their pocket.

That is why we build things.

---

Want to see what StatBreaks would look like if we built it today with AI? We wrote that too: If We Built StatBreaks Today, AI Would Watch the Floor So You Don't Have To.